Literature DB >> 18476108

Screening for human immunodeficiency virus in inner city females with abnormal cervical cytology.

T S Jennings1, P Dottino, R Sperling, A M Beddoe.   

Abstract

OBJECTIVE: This report evaluates the acceptance, results, and predictors of human immunodeficiency virus (HIV) infection in inner city women referred to a colposcopy clinic for abnormal cervical cytology.
METHODS: HIV testing results of 1,908 inner city women referred for abnormal cervical cytology were analyzed retrospectively with respect to acceptance, race, ethnicity, Pap smear results, sexually transmitted diseases (STDs), HIV exposures, and final histologic findings.
RESULTS: HIV testing was accepted by 50.4% of patients. Women who agreed to screening were significantly more likely to admit exposure to HIV or to be Hispanic, foreign-born, or have a history of multiple STDs. Of those screened, 3.3% were found to be HIV seropositive. Although higher grades of referral Pap smears were noted in the women found to be HIV seropositive, final histologic findings were not different. The only predictors of unknown HIV seropositivity were admitted HIV exposure and external condyloma.
CONCLUSIONS: Fifty percent of inner city women of unknown HIV status referred for abnormal cervical cytology will accept HIV serotesting and 3.3% are found to be positive. Most HIV-seropositive women can be detected based on either a history of exposure to HIV or the presence of external condyloma.

Entities:  

Year:  1996        PMID: 18476108      PMCID: PMC2364508          DOI: 10.1155/S1064744996000543

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  15 in total

1.  Acceptability of screening for HIV seroprevalence in women with cervical pathology.

Authors:  K H McCarthy; M A Johnson; F G Lawton; J W Studd
Journal:  Lancet       Date:  1992-10-24       Impact factor: 79.321

2.  Prevalence of human immunodeficiency virus in a colposcopy clinic.

Authors:  M Maiman; R G Fruchter; E Serur; J G Boyce
Journal:  JAMA       Date:  1988-10-21       Impact factor: 56.272

Review 3.  A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents.

Authors:  I D Rotkin
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

Review 4.  Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions.

Authors:  J S Mandelblatt; M Fahs; K Garibaldi; R T Senie; H B Peterson
Journal:  AIDS       Date:  1992-02       Impact factor: 4.177

5.  Interaction of human immunodeficiency and papilloma viruses: association with anal epithelial abnormality in homosexual men.

Authors:  D Caussy; J J Goedert; J Palefsky; J Gonzales; C S Rabkin; R A DiGioia; W C Sanchez; R J Grossman; G Colclough; S Z Wiktor
Journal:  Int J Cancer       Date:  1990-08-15       Impact factor: 7.396

6.  Human immunodeficiency virus infection and invasive cervical carcinoma.

Authors:  M Maiman; R G Fruchter; L Guy; S Cuthill; P Levine; E Serur
Journal:  Cancer       Date:  1993-01-15       Impact factor: 6.860

7.  Rapidly progressive squamous cell carcinoma of the cervix coexisting with human immunodeficiency virus infection: clinical opinion.

Authors:  L B Schwartz; M L Carcangiu; L Bradham; P E Schwartz
Journal:  Gynecol Oncol       Date:  1991-06       Impact factor: 5.482

8.  Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection.

Authors:  M Laga; J P Icenogle; R Marsella; A T Manoka; N Nzila; R W Ryder; S H Vermund; W L Heyward; A Nelson; W C Reeves
Journal:  Int J Cancer       Date:  1992-01-02       Impact factor: 7.396

9.  Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.

Authors:  J ter Meulen; H C Eberhardt; J Luande; H N Mgaya; J Chang-Claude; H Mtiro; M Mhina; P Kashaija; S Ockert; X Yu
Journal:  Int J Cancer       Date:  1992-06-19       Impact factor: 7.396

Review 10.  Voluntary screening for human immunodeficiency virus (HIV) infection. Weighing the benefits and harms.

Authors:  B Lo; R L Steinbrook; M Cooke; T J Coates; E J Walters; S B Hulley
Journal:  Ann Intern Med       Date:  1989-05-01       Impact factor: 25.391

View more
  1 in total

Review 1.  HIV testing in termination of pregnancy and colposcopy services: a scoping review.

Authors:  Paraskevas Filippidis; Katyuska Francini; Martine Jacot-Guillarmod; Patrice Mathevet; Loïc Lhopitallier; Matthias Cavassini; Katharine E A Darling
Journal:  Sex Transm Infect       Date:  2021-09-20       Impact factor: 3.519

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.